Dr. James Daniel Fondren, MD

Dr. Fondren practices at David Benvenuti, M.D. F.A.C.S. in Newport Beach, California.

Dr. Fondren's NPI, 1598781213, was assigned on July 14, 2006. Dr. Fondren graduated from Keck School of Medicine of USC in 1995. Dr. Fondren holds California license A60586.

Dr. Fondren's primary practice is David Benvenuti, M.D. F.A.C.S., at 355 Placentia Ave, Newport Beach, CA 92663 in Orange County. The practice phone is (949) 650-2345.

Dr. Fondren's primary practice is David Benvenuti, M.D. F.A.C.S. in Newport Beach, California. Dr. Fondren is also affiliated with Hoag Hospital Newport Beach. Dmand AI also links Dr. Fondren to 4 more home health agencies, 1 physician office and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fondren practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Fondren's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Fondren is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Fondren's licenses on file in 2 states: California and Nevada.

Dmand AI lists acute sinusitis, acute skin infection, adjustment disease, alzheimer's disease, anxiety, asthma, atrial fibrillation and flutter and bronchitis among the conditions Dr. Fondren treats.

CMS data shows 1,286 Medicare services from Dr. Fondren across 12 procedure codes in 2024, for 225 Medicare patients. Medicare paid $88,486 for them. Every service was in an office.

CMS counts 225 Medicare patients who saw Dr. Fondren in 2024. The largest group is 75 to 84, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fondren's median patient age at 78, with 48% women.

In 2024, Dr. Fondren wrote 4,918 Medicare Part D claims for 244 patients. 85% of them were for generic drugs. CMS names the drug for 4,175 of them, across 107 drugs with 11 or more claims each, at $435,320 in total drug cost. In 2023, CMS named 4,092 claims across 109 drugs.

Dr. Fondren accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 28 general payments to Dr. Fondren from 6 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $474. It also lists 1 research payment totaling $150 in 2020.

Dr. Fondren graduated from Keck School of Medicine of USC in 1995. Dr. Fondren is a member of ACP.

Dr. Fondren is in network with 6 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.